We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Vertex Pharmaceuticals (Europe) Limited

2 Kingdom Street, London, W2 6BD, UK
Telephone: +44 (0)20 3204 5100
Fax: +44 (0)20 3204 5220
Medical Information Direct Line: +44 (0)1923 437 672
Medical Information e-mail: eumedicalinfo@vrtx.com
Customer Care direct line: +44 (0)1923 437 672
Medical Information Facsimile: +44 (0)1235 438 190
Patient Information Leaflet last updated on medicines.ie: 13/09/2017
PIL Orkambi 200 mg/125 mg film coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 13/09/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - what you need to know - warnings and precautions
  • Change to section 4 - possible side effects
Updated on 05/05/2017 and displayed until 13/09/2017
Reasons for adding or updating:
  • Change to section 4 - how to report a side effect
Updated on 09/06/2016 and displayed until 05/05/2017
Reasons for adding or updating:
  • Change to warnings or special precautions for use
Updated on 18/01/2016 and displayed until 09/06/2016
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Ivacaftor
   Lumacaftor